1. Pharmaceutical Patents in Europe: Radical Reforms Rather Than Getting Rid?

   • Livio Garattini
   • Bruno Finazzi

   Editorial 29 November 2021 Pages: 453 - 455

2. Data-Related Challenges in Cost-Effectiveness Analyses of Vaccines

   • Jamison Pike
   • Andrew J. Leidner
   • Scott D. Grosse

   Practical Application 09 February 2022 Pages: 457 - 465

3. Korean Guidelines for Pharmacoeconomic Evaluations: Updates in the Third Version

   • Eun-Young Bae
   • Jihyung Hong
   • Tae-jin Lee

   Leading Article 11 March 2022 Pages: 467 - 477

   

4. Modelling the Future Clinical and Economic Burden of Antimicrobial Resistance: The Feasibility and Value of Models to Inform Policy

   • Nadine T. Hillock
   • Tracy L. Merlin
   • Jonathan Karnon

   Review Article Open access 04 April 2022 Pages: 479 - 486

   

5. A Case Study on Reviewing Specialist Services Commissioning in Wales: TAVI for Severe Aortic Stenosis

   • Edyta Ryczek
   • Susan C. Peirce
   • Sian Lewis

   Review Article Open access 25 February 2022 Pages: 487 - 499

   

6. Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options

   • Rositsa Koleva-Kolarova
   • James Buchanan
   • The HEcoPerMed Consortium

   Systematic Review Open access 04 April 2022 Pages: 501 - 524

   

7. What Policy Approaches Were Effective in Reducing Catastrophic Health Expenditure? A Systematic Review of Studies from Multiple Countries

   • HyunWoo Jung
   • Kwang-Soo Lee

   Systematic Review 14 March 2022 Pages: 525 - 541

   

8. Cost-Effectiveness of Once-Weekly Semaglutide 1 mg versus Canagliflozin 300 mg in Patients with Type 2 Diabetes Mellitus in a Canadian Setting

   • Sara Stafford
   • Peter G. Bech
   • Aiden Liu

   Original Research Article Open access 28 March 2022 Pages: 543 - 555

   

9. How Responsive is Mortality to Locally Administered Healthcare Expenditure? Estimates for England for 2014/15

   • Stephen Martin
   • Karl Claxton
   • Francesco Longo

   Original Research Article 14 March 2022 Pages: 557 - 572

10. Population Norms for SF-6Dv2 and EQ-5D-5L in China

    • Shitong Xie
    • Jing Wu
    • Feng Xie

    Original Research Article 08 February 2022 Pages: 573 - 585

    

11. Economic Evaluation of Oral Nucleos(t)ide Analogues for Patients with Chronic Hepatitis B in Thailand

    • Piyameth Dilokthornsakul
    • Ratree Sawangjit
    • Unchalee Permsuwan

    Original Research Article 10 February 2022 Pages: 587 - 596

    

12. Preferred Attributes of Care Pathways for Obstructive Sleep Apnoea from the Perspective of Diagnosed Patients and High-Risk Individuals: A Discrete Choice Experiment

    • Andrea N. Natsky
    • Andrew Vakulin
    • Billingsley Kaambwa

    Original Research Article Open access 10 February 2022 Pages: 597 - 607

13. Cost Effectiveness of Ribociclib and Palbociclib in the Second-Line Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer in Post-Menopausal Indian Women

    • Nidhi Gupta
    • Dharna Gupta
    • Shankar Prinja

    Original Research Article 10 May 2022 Pages: 609 - 621

    

14. Correction to: Cost-Effectiveness of Once-Weekly Semaglutide 1 mg versus Canaglifozin 300 mg in Patients with Type 2 Diabetes Mellitus in a Canadian Setting

    • Sara Stafford
    • Peter G. Bech
    • Aiden Liu

    Correction Open access 20 April 2022 Pages: 623 - 623